Goodrich Leasing

Blueprint Medicines, based in Cambridge, MA, is dedicated to transforming groundbreaking science into innovative therapies that significantly improve patient lives. With a strong focus on allergic inflammatory diseases and cancer, the company seeks to pioneer novel solutions by targeting the root causes of disease through a diverse and passionate team. Their commitment to accelerating the development of new treatments is reflected in their robust pipeline and dedication to clinical research. By fostering a collaborative environment that values diversity and bold decision-making, Blueprint Medicines aims to revolutionize the medical landscape and extend the time patients can enjoy with their loved ones. Generated from the website

Epizyme, Inc is a global biopharmaceutical leader focused on developing innovative medicines in oncology, neuroscience, and rare diseases. The company is dedicated to improving lives through cutting-edge research and the development of transformative therapies. Generated from their website's infomation

KalVista Pharmaceuticals, based in Cambridge, MA, is dedicated to advancing science to empower individuals living with hereditary angioedema (HAE). Through innovative research and the development of orally delivered small molecule medicines, the company aims to transform the treatment landscape for HAE patients by addressing their unmet needs. With a team of skilled professionals and experienced scientists, KalVista is focused on elevating the standard of care for patients suffering from various diseases, starting with HAE. Their lead product, sebetralstat, represents a potential new oral treatment option designed to enhance the management of this challenging condition. Generated from the website